XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis

Nikos Maniadakis; Vasilios Fragoulakis

首页> 外文期刊>Current medical research and opinion >XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis

【24h】

XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis

机译：Xelox与Folfox6作为结肠直肠癌的佐剂治疗：经济分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: An economic analysis (based on interim data from a long-term, randomised, multi-centre, controlled, clinical trial) to evaluate chemotherapy with XELOX (capecitabine/oxaliplatin) versus FOLFOX6 (5Fluorouracil/leucovorin/oxaliplatin) as an adjuvant treatment for high risk colorectal cancer patients in Greece.

机译：目的：经济分析（基于来自长期，随机，多中心，受控，临床试验）的经济分析，以评估与Xelox（Capecitabine / Oxaliplatin）与Folfox6（5fluorouracil / Leucovorin / Oxaliplatin）进行化疗的化疗作为佐剂治疗对于希腊的高风险结直肠癌患者。

著录项

来源
《Current medical research and opinion》 |2009年第3期|共9页
作者
Nikos Maniadakis; Vasilios Fragoulakis;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis [J] . Nikos Maniadakis, Vasilios Fragoulakis Current medical research and opinion . 2009,第3期

机译：Xelox与Folfox6作为结肠直肠癌的佐剂治疗：经济分析
2. Population-Based Cost-Minimization Analysis of CAPOX Versus Modified FOLFOX6 in the Adjuvant Treatment of Stage III Colon Cancer [J] . Ho Maria Y., Chang Albert Y., Ruan Jenny Y., Clinical colorectal cancer . 2016,第2期

机译：CAPOX与修饰的FOLFOX6在第三阶段结肠癌辅助治疗中基于人群的费用最小化分析
3. Cost-effectiveness analysis of XELOX versus XELOX plus bevacizumab for metastatic colorectal cancer in a public hospital school [J] . Andrea Queiróz Ungari, Leonardo Régis Leira Pereira, Altacílio Aparecido Nunes, BMC Cancer . 2017,第1期

机译：XELOX与XELOX联合贝伐单抗治疗公立医院转移性结直肠癌的成本效益分析
4. PHASE III COMPARISON OF CARBOPLATIN VERSUS CARBOPLATIN AND DOXORUBICIN FOR THE ADJUVANT TREATMENT OF APPENDICULAR OSTEOSARCOMA: INTERIM ANALYSIS [C] . Katherine Skorupski, Justin Uhl, Stephen Shaw, Annual Conference of the Veterinary Cancer Society . 2009

机译：Carboplatin与Carboplatin和多柔比星的相位III比较，用于辅助骨肉瘤的佐剂治疗：临时分析
5. Cost-Benefit Analysis of Nanoparticle Albumin-Bound Paclitaxel versus Solvent-Based Paclitaxel for the Treatment of Metastatic Breast Cancer in the United States [D] . Vichansavakul, Kittaya 2013

机译：纳米白蛋白结合紫杉醇与溶剂型紫杉醇在美国治疗转移性乳腺癌的成本效益分析
6. The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status [O] . Thierry André, Timothy Iveson, Roberto Labianca, -1

机译：IDEA（国际辅助化疗持续时间评估）合作：III期试验的前瞻性联合分析研究针对III期结肠癌患者的FOLFOX（FOLFOX4或改良的FOLFOX6）或XELOX（3个月至6个月）方案的辅助治疗的持续时间的III期试验：试验设计与现状
7. The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status [O] . Thierry André, null null, Timothy Iveson, 2013

机译：IDEA（国际辅助化疗持续时间评估）合作：III期试验的前瞻性联合分析，研究针对III期结肠癌患者的FOLFOX（FOLFOX4或改良的FOLFOX6）或XELOX（3个月至6个月）方案的辅助治疗的持续时间的III期试验：试验设计与现状

XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis

摘要

著录项

相似文献

相关主题

期刊订阅